An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.
New Strong Buy Stocks for May 4th
Last week, you might have seen that Zynex, Inc. (NASDAQ:ZYXI) released its yearly result to the market. The early...
Top Ranked Momentum Stocks to Buy for May 5th
It's really great to see that even after a strong run, Zynex (NASDAQ:ZYXI) shares have been powering on, with a gain...
Q1 2020 Zynex Inc Earnings Call
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2020.
Zynex has been struggling lately, but the selling pressure may be coming to an end soon.
Q4 2019 Zynex Inc Earnings Call
As of late, it has definitely been a great time to be an investor Zynex
Zacks.com featured highlights include: ThermoGenesis, Minerva, Sprout Social, Black Diamond and Zynex
My name is Thomas Sandgaard, President and CEO of Zynex. The investment in expanding our sales force continues to progress as we expand our geographic footprint across the US. This order growth is a result of aggressively adding new sales reps to the sales force every month and the steep order growth is a continued sign of strong demand for our products.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has introduced a full catalog of physical therapy products for distribution through its US sales force.
Two Medical Products Stocks with Recent Price Strength.
Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2020 first quarter investor webcast on Tuesday, April 28, 2020 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLabs, ...
The Dow Jones Industrial Average is demonstrating resilience, erasing an early 2% loss, unfazed by news of another big surge in weekly jobless claims.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it has hired Rachelle (Chelle) Van Burkleo as its Vice President of Sales.
Anyone researching Zynex, Inc. (NASDAQ:ZYXI) might want to consider the historical volatility of the share price...